Literature DB >> 22761983

Portal vein thrombosis following percutaneous transhepatic cholangiography-An unusual presentation of Prothrombin (Factor II) gene mutation.

Ian M Brennan1, Muneeb Ahmed.   

Abstract

Portal vein thrombosis is an uncommonly reported complication of percutaneous transhepatic cholangiography (PTC). A thorough review of the available literature shows no reported cases. In this case, a 29 year old female presented on two separate occasions with portal vein thrombosis following PTC without drain placement. This unusual complication of image guided percutaneous biliary access is unreported in the literature and prompted evaluation of the patient's coagulation parameters. A thrombophilia screen demonstrated a mutation in the Prothrombin (Factor II) gene. A thorough literature review shows no reported cases of portal vein thrombosis following percutaneous biliary access, is an unusual complication, and should raise suspicion of an underlying pro-coagulant state.

Entities:  

Keywords:  Hereditary thrombophilia; Percutaneous transhepatic cholangiography; Portal vein thrombosis; Prothrombin gene mutation

Year:  2012        PMID: 22761983      PMCID: PMC3386535          DOI: 10.4329/wjr.v4.i5.224

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  13 in total

1.  Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler.

Authors:  N von Ahsen; E Schütz; V W Armstrong; M Oellerich
Journal:  Clin Chem       Date:  1999-05       Impact factor: 8.327

2.  Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma.

Authors:  Rong Qin Zheng; Masatoshi Kudo; Kanae Inui; Yoichiro Suetomi; Yasunori Minami; Hobyung Chung; Toshihiko Kawasaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

Review 3.  Review article: the modern management of portal vein thrombosis.

Authors:  Y Chawla; A Duseja; R K Dhiman
Journal:  Aliment Pharmacol Ther       Date:  2009-08-12       Impact factor: 8.171

4.  Frequent factor II G20210A mutation in idiopathic portal vein thrombosis.

Authors:  P Chamouard; E Pencreach; F Maloisel; L Grunebaum; J F Ardizzone; A Meyer; M P Gaub; J Goetz; R Baumann; B Uring-Lambert; S Levy; P Dufour; G Hauptmann; P Oudet
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

5.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

Authors:  S R Poort; F R Rosendaal; P H Reitsma; R M Bertina
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

Review 6.  Portal vein thrombosis.

Authors:  Jing-Tong Wang; Hui-Ying Zhao; Yu-Lan Liu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-11

7.  Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma.

Authors:  Daiki Habu; Shuhei Nishiguchi; Susumu Shiomi; Akihiro Tamori; Hiroki Sakaguchi; Tadashi Takeda; Shuichi Seki; Chika Ishibashi; Hitoshi Asai
Journal:  Indian J Gastroenterol       Date:  2002 Jul-Aug

8.  Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.

Authors:  Mats Ogren; David Bergqvist; Martin Björck; Stefan Acosta; Henry Eriksson; Nils H Sternby
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 9.  Etiology and consequences of thrombosis in abdominal vessels.

Authors:  Yusuf Bayraktar; Ozgur Harmanci
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

10.  Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis.

Authors:  Francesco Dentali; Matteo Galli; Monica Gianni; Walter Ageno
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.